[go: up one dir, main page]

AU2002226059A1 - Improved compositions and methods for producing antibodies to low molecular weight analytes - Google Patents

Improved compositions and methods for producing antibodies to low molecular weight analytes

Info

Publication number
AU2002226059A1
AU2002226059A1 AU2002226059A AU2605902A AU2002226059A1 AU 2002226059 A1 AU2002226059 A1 AU 2002226059A1 AU 2002226059 A AU2002226059 A AU 2002226059A AU 2605902 A AU2605902 A AU 2605902A AU 2002226059 A1 AU2002226059 A1 AU 2002226059A1
Authority
AU
Australia
Prior art keywords
methods
molecular weight
low molecular
producing antibodies
improved compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002226059A
Inventor
Richard B Cook
Calvin A. Saravis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TransDerm Technologies LLC
Original Assignee
TransDerm Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TransDerm Technologies LLC filed Critical TransDerm Technologies LLC
Publication of AU2002226059A1 publication Critical patent/AU2002226059A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU2002226059A 2000-12-15 2001-12-12 Improved compositions and methods for producing antibodies to low molecular weight analytes Abandoned AU2002226059A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25618000P 2000-12-15 2000-12-15
US60/256,180 2000-12-15
PCT/US2001/047544 WO2002048675A2 (en) 2000-12-15 2001-12-12 Improved compositions and methods for producing antibodies to low molecular weight analytes

Publications (1)

Publication Number Publication Date
AU2002226059A1 true AU2002226059A1 (en) 2002-06-24

Family

ID=22971344

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002226059A Abandoned AU2002226059A1 (en) 2000-12-15 2001-12-12 Improved compositions and methods for producing antibodies to low molecular weight analytes

Country Status (4)

Country Link
US (1) US20030049800A1 (en)
EP (1) EP1351989A2 (en)
AU (1) AU2002226059A1 (en)
WO (1) WO2002048675A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100354308C (en) * 2003-10-23 2007-12-12 中国人民解放军军医进修学院 Novel alginate monoclonal antibody and its preparation method and uses
CN101921338A (en) * 2004-03-31 2010-12-22 佳能株式会社 Gold-binding protein and use thereof
CN101914154A (en) * 2010-07-05 2010-12-15 吉林大学 A kind of Hg2+ antigen and corresponding monoclonal antibody and preparation method thereof
CN102128920B (en) * 2010-11-11 2013-08-21 暨南大学 Immunological method for quickly detecting heavy metal lead ions and kit
CN105377433A (en) * 2013-05-14 2016-03-02 菲帛罗缇埃克斯有限公司 Lateral flow assay device
CN110408599A (en) * 2018-12-10 2019-11-05 浙江工商大学 A hybridoma cell line secreting anti-heavy metal lead ion monoclonal antibody and its application
CN110408598A (en) * 2018-12-10 2019-11-05 浙江工商大学 A hybridoma cell line secreting anti-heavy metal lead ion monoclonal antibody and its application

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807715A (en) * 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
US4722892A (en) * 1984-08-31 1988-02-02 Meares Claude F Monoclonal antibodies against metal chelates
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5972656A (en) * 1989-03-14 1999-10-26 Bionebraska, Inc. Mercury binding polypeptides and nucleotides coding therefore
CA2047717C (en) * 1989-03-14 2000-08-01 Fred W. Wagner Monoclonal antibodies for small moieties, methods therefor
US5639624A (en) * 1989-03-14 1997-06-17 Board Of Regents Of The University Of Nebraska Monoclonal antibodies specific for metallic cations and method therefor
DE4007079A1 (en) * 1990-03-07 1991-09-12 Behringwerke Ag MONOCLONAL ANTICOERPERS AGAINST COMPLEXED AND UNPLEPLIED COMPLEX IMAGES FOR THE REMOVAL OF HEAVY METALS FROM WAESSEN SOLUTIONS
WO1992002551A1 (en) * 1990-08-02 1992-02-20 B.R. Centre Limited Methods for the production of proteins with a desired function
DE122004000008I1 (en) * 1991-06-14 2005-06-09 Genentech Inc Humanized heregulin antibody.
WO1994004679A1 (en) * 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
US5869619A (en) * 1991-12-13 1999-02-09 Xoma Corporation Modified antibody variable domains
JP4157160B2 (en) * 1991-12-13 2008-09-24 ゾーマ テクノロジー リミテッド Methods for the preparation of modified antibody variable regions
US6180377B1 (en) * 1993-06-16 2001-01-30 Celltech Therapeutics Limited Humanized antibodies
US5532136A (en) * 1993-06-22 1996-07-02 Bionebraska, Inc. Monoclonal antibody assay and kit for detecting metal cations in body fluids
US5476939A (en) * 1993-12-30 1995-12-19 Abbott Laboratories Certain pyridyl and isoquinolyl carbinolamine derivatives
US6111079A (en) * 1995-06-05 2000-08-29 Bionebraska, Inc. Lead binding polypeptides and nucleotides coding therefore
US6013256A (en) * 1996-09-24 2000-01-11 Protein Design Labs, Inc. Method of preventing acute rejection following solid organ transplantation
US6248268B1 (en) * 1998-11-16 2001-06-19 Xc Corporation Process of making microparticles of a thermally-gelled polysaccharide

Also Published As

Publication number Publication date
WO2002048675A3 (en) 2003-03-13
WO2002048675A2 (en) 2002-06-20
US20030049800A1 (en) 2003-03-13
EP1351989A2 (en) 2003-10-15

Similar Documents

Publication Publication Date Title
AU2001294198A1 (en) Cells producing antibody compositions
AU9419801A (en) Cells producing antibody compositions
AU2002354929A1 (en) Antibodies specific for nanotubes and related methods and compositions
AU2002222112A1 (en) Hybrid antibodies
AU2001294175A1 (en) Method of purifying antibody
EP2270052B8 (en) Antibodies to OPGL
AU2001276048A1 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
AU2001279284A1 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
HUP0302376A3 (en) Anti-tnf antibodies, compositions, methods and uses
AU2001240115A1 (en) Method for the preparation of tetrahydrobenzothiepines
WO2002030986A3 (en) HUMANIZED ANTI-LT-β-R ANTIBODIES
AU2001263155A1 (en) Methods and compositions for interaction trap assays
AU2002220843A1 (en) Humanised antibodies and uses thereof
AU2001236916A1 (en) Techniques to facilitate shopping for projects
AU2002234076A1 (en) Construction composition, structure, and method
AU2002232819A1 (en) Methods for the production of multimeric proteins, and related compositions
AU2001271502A1 (en) Methods and compositions for isolating biologically active antibodies
AU2001294132A1 (en) Alcohol-free perfuming composition
AU2002359495A1 (en) Anti-tnf antibodies, compositions, methods and uses
AU2002217089A1 (en) Method for producing sulfonamide-substituted imidazotriazinones
AU2001270321A1 (en) Method for making or adding structures to an article
AU2002315066A1 (en) Methods for making antibody fragments and compositions resulting therefrom
AU2002226059A1 (en) Improved compositions and methods for producing antibodies to low molecular weight analytes
AU2001268232A1 (en) Compositions, methods, and kits relating to resistin-like molecules
AU2002365269A1 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses